Economic burden of glaucoma in Rivers State, Nigeria
Economic burden of glaucoma in Rivers State, Nigeria
复制标题
DOI：
10.2147/opth.s37145
复制
发表时间：
2012-01-01
影响因子：
2.2
通讯作者：
Onua, Alfred A.
中科院分区：
文献类型：
--
作者：
Adio, Adedayo O.;Onua, Alfred A.
背景资料：据报道，原发性开角型青光眼使尼日利亚人口中的150，000人失明，在里弗斯州超过7000人失明，并且需要持续随访。鉴于大多数居民生活在贫困线以下，遵守规定是一项挑战。本研究进行，以确定尼日利亚患者是如何影响经济的diseases.Methods：连续成人患者参加眼科诊所的大学哈科特港教学医院，里弗斯州，尼日利亚，诊断原发性开角型青光眼和门诊抗青光眼治疗在2006年的前6个月，被招募为研究。最低工资的政府工作人员是每月50美元（N7500.00），人均国内生产总值为1150美元，在审查期间。结果：我们招募了120名连续患者，平均年龄52.7 +/- 10.4岁，男女比例为2：3。最常见的职业是公务员（n = 56，46.7%）。所有参与者均接受局部抗青光眼治疗。抗青光眼药物的平均费用为每月N6000（USD 40）。计算包括间接费用，包括医学实验室检查，运输和患者护送护理，平均每位患者每月花费105.4美元（N15，810）。大部分患者（73.3%）的治疗费用由自己承担。没有患者接受更便宜的手术选择（275.4美元，N41，310）。80例患者（66.7%）每月到我们的眼科诊所就诊。盲人每年给经济造成的直接和间接损失为3，064587美元。这是除了每年花费410万美元的青光眼视力受损者的医疗费用。结论：中等收入者花费超过50%的月收入和低收入者花费所有的月收入用于治疗青光眼。这种情况往往导致不遵守治疗和医院随访。为了减轻青光眼的经济负担，在这个国家，由经验丰富的外科医生进行的小梁切除术应该作为青光眼的一线治疗，而不是药物治疗。
Background: Primary open angle glaucoma is reported to blind 150,000 people in the Nigerian population and over 7000 in Rivers State, and requires constant follow-up. Compliance is a challenge, given that most inhabitants live below the poverty line. This study was performed to determine how Nigerian patients are affected economically by the disease.Methods: Consecutive adult patients attending the eye clinic of the University of Port Harcourt Teaching Hospital, Rivers State, Nigeria, with a diagnosis of primary open angle glaucoma and on outpatient antiglaucoma treatment in the first 6 months of 2006, were recruited for the study. The lowest paid government worker was on USD50 (N7500.00) per month and the gross domestic product per capita was USD1150 for the period under review.Results: We enrolled 120 consecutive patients of mean age 52.7 +/- 10.4 years, with a male to female ratio of 2: 3. The most common occupations were in the civil service (n = 56, 46.7%). All participants were on topical antiglaucoma treatment. The average cost of medical antiglaucoma medication was N6000 (USD40) per month. Computed to include indirect costs, including medical laboratory tests, transportation, and care by patient escorts, an average sum of USD105.4 (N15,810) was spent by each patient per month. Most of the patients (73.3%) were responsible for their own treatment costs. No patient accepted the cheaper option of surgery (USD275.4, N41,310). Eighty of the patients (66.7%) visited our eye clinic monthly. Direct and indirect loss to the economy was USD3,064587 per annum from those already blind. This was in addition to the USD 4.1 million being spent yearly on medical treatment by those who were visually impaired by glaucoma.Conclusion: Middle-income earners spent over 50% of their monthly income and low-income earners spend all their monthly earnings on treatment for glaucoma. This situation often resulted in noncompliance with treatment and hospital follow-up visits. To reduce the economic burden of glaucoma, trabeculectomy performed by experienced surgeons should be offered as first-line treatment for glaucoma in this country, rather than medical therapy.